
Uricift-D Tablet MR
Marketer
Biophar Lifesciences Pvt Ltd
Salt Composition
Tamsulosin (0.4mg) + Dutasteride (0.5mg)
Overview Uricift-D Tablet MR
Prostaduo MR tablets combine two active ingredients with distinct mechanisms to manage benign prostatic hyperplasia (BPH) in adult males. This medication alleviates symptoms like frequent urination and difficulty voiding. It does not prevent prostate cancer. Prostaduo MR can be taken with or without food, but consistently at the same time daily, as prescribed by your physician. Consistent use is crucial for optimal symptom control; even if feeling well, do not skip doses. Symptom improvement may take up to a month; continue regular use. Report any lack of improvement or worsening symptoms after four weeks. Common side effects include erectile dysfunction, reduced libido, breast tenderness, and ejaculatory problems. Consult your doctor if these persist or are bothersome. Dizziness or drowsiness may occur, particularly initially. Your doctor has prescribed this medication because the benefits outweigh potential side effects. Prostaduo MR is contraindicated in women and children. Inform your doctor of any pre-existing conditions like low blood pressure, liver, or kidney disease before starting treatment. Interactions with other medications are possible; disclose all current medications. Condom use during sex is recommended if your partner is, or may become, pregnant. Regular blood pressure monitoring may be advised. Alcohol consumption should be avoided due to the increased risk of dizziness.
Uses of Uricift-D Tablet MR
Managing benign prostatic hyperplasia
Major Benefits of Uricift-D Tablet MR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or fracture it. Uricift-D MR tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Uricift-D Tablet MR:
- Impotence
- Decreased libido
- Ejaculation disorder
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breast enlargement in male
- Breast tenderness in male
- Dizziness
How to use Uricift-D Tablet MR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Uricift-D Tablet MR whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
How Uricift-D Tablet MR works:
Uricift-D MR tablets contain Tamsulosin and Dutasteride, offering dual action for benign prostatic hyperplasia (BPH) symptom relief. Tamsulosin, an alpha-adrenergic blocker, eases urination by relaxing prostate and bladder neck muscles. Dutasteride, a 5-alpha-reductase inhibitor, reduces prostate size by lowering levels of a hormone that stimulates prostate growth.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Uricift-D MR tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Uricift-D Tablet MR use in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Uricift-D Tablet MR use while breastfeeding is absent. Seek medical advice.
DrivingUNSAFE
Taking Uricift-D Tablet MR might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Uricift-D Tablet MR use in patients with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Uricift-D Tablet MR, potentially requiring dosage modification. Physician consultation is advised. Uricift-D Tablet MR is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Uricift-D Tablet MR :
Should you forget a Uricift-D Tablet MR dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Uricift-D Tablet MR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urology |
